C92 J18
Conditions
Interventions
Group 1: Physiotherapeutic standard therapy by local standard with additional respiration therapy with the PEP-trainer Mediflo duo (3 times daily 10 expirations)
Group 2: Physiotherapeutic standard th
Sponsors
Vivantes Klinikum Neukölln - Hämatologie, Onkologie und Palliativmedizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patient with AML under first-line high dose chemotherapy treated as in-patient under curative intention (OR patients under high dose chemotherapy with consecutive autologous stem cell transplantation - extended additional study population) . 2. Informed consent
Exclusion criteria
Exclusion criteria: 1. Patient with diagnosed pulmonary infection at study start. 2. Patient with known primary immunodeficiency or uncontrolled HIV infection (Patients with known HIV infection but controlled disease, normal CD4 count and undetectable HIV virus load can participate). 3. Patients with COPD GOLD III or IV or severe bronchial asthma. 4. Patients with known infectious pulmonary disease. 5. Patient unwilling or able to perform physio- and respiration therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Radiological confirmed pneumonia | — |
Secondary
| Measure | Time frame |
|---|---|
| a) Severe clinical events (sepsis, admission to ICU, death) b) Analysis of administered anti-infective drugs and time of treatment. c) Number of hospital days | — |
Countries
Germany
Contacts
Public ContactTil Kiderlen
Vivantes Klinikum Neukölln - Hämatologie, Onkologie und Palliativmedizin
Outcome results
None listed